Posted inNews and Updates
China Emerges as Global Powerhouse for Clinical Trials
China is rapidly becoming a global leader in medical research. Learn how regulatory reforms and infrastructure growth are shaping its clinical trial sector.
Posted inNews and Updates
BioVie Parkinson’s Trial Fails to Meet Primary Endpoint
BioVie shares plummet as Phase IIb study for Parkinson’s treatment NE3107 fails to meet primary endpoints in motor function improvement trials.
Posted inNews and Updates
Betting on Clinical Trials: Ethics and Risks Examined
The rise of betting on clinical trial outcomes sparks ethical concerns among experts. Discover the risks these prediction markets pose to medical research.
Posted inNews and Updates
AI Transforms Drug Discovery: Solving the $2B Problem
Discover how AI is revolutionizing drug development, reducing the $2 billion cost of research, and accelerating the path to life-saving medical breakthroughs.
Posted inNews and Updates
FDA Approves Tudriqev for Advanced Melanoma Treatment
The FDA has approved Tudriqev for advanced melanoma, offering a new treatment pathway for patients who have developed resistance to anti-PD-1 therapies.
Posted inNews and Updates
Heart Drug Trial Fails: New Anti-Inflammatory Setback
A promising new heart drug targeting inflammation has failed its latest clinical trial, missing key efficacy endpoints for preventing heart attacks.
Posted inNews and Updates
AI Remains Underutilized in Clinical Trial Operations
Clinical trials are falling behind in AI adoption. Discover why industry leaders say underutilization of technology is stalling medical innovation.
Posted inNews and Updates
New BathMat Tool Improves ICU Patient Care and Efficiency
The BathMat sensor technology is revolutionizing ICU care by reducing nursing workloads and improving patient monitoring for better clinical outcomes.
Posted inNews and Updates
Dronabinol and PTSD: Lessons for CNS Clinical Trials
New trial data on Dronabinol for PTSD highlights critical gaps in CNS clinical trial design. Learn why trial methodology is failing to capture efficacy.
Posted inNews and Updates
Tenaya TN-201 Gene Therapy Shows Promise in HCM Trial
Tenaya's TN-201 gene therapy shows breakthrough results in reducing heart muscle thickness for HCM patients. Discover the latest clinical trial data.